- Home
- KALA vs GTIM Comparison
KALA vs GTIM Comparison
Compare KALA & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- GTIM
- Stock Information
- Founded
- KALA 2009
- GTIM 1987
- Country
- KALA United States
- GTIM United States
- Employees
- KALA 43
- GTIM N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- GTIM Restaurants
- Sector
- KALA Health Care
- GTIM Consumer Discretionary
- Exchange
- KALA Nasdaq
- GTIM Nasdaq
- Market Cap
- KALA 27.3M
- GTIM 28.9M
- IPO Year
- KALA 2017
- GTIM 1990
- Fundamental
- Price
- KALA $5.92
- GTIM $2.51
- Analyst Decision
- KALA Strong Buy
- GTIM
- Analyst Count
- KALA 2
- GTIM 0
- Target Price
- KALA $15.00
- GTIM N/A
- AVG Volume (30 Days)
- KALA 31.3K
- GTIM 15.7K
- Earning Date
- KALA 11-12-2024
- GTIM 12-12-2024
- Dividend Yield
- KALA N/A
- GTIM N/A
- EPS Growth
- KALA N/A
- GTIM N/A
- EPS
- KALA N/A
- GTIM 0.14
- Revenue
- KALA N/A
- GTIM $142,315,000.00
- Revenue This Year
- KALA N/A
- GTIM N/A
- Revenue Next Year
- KALA N/A
- GTIM N/A
- P/E Ratio
- KALA N/A
- GTIM $17.93
- Revenue Growth
- KALA N/A
- GTIM 3.01
- 52 Week Low
- KALA $4.21
- GTIM $2.18
- 52 Week High
- KALA $9.25
- GTIM $3.45
- Technical
- Relative Strength Index (RSI)
- KALA 41.69
- GTIM 37.61
- Support Level
- KALA $5.67
- GTIM $2.50
- Resistance Level
- KALA $6.23
- GTIM $2.59
- Average True Range (ATR)
- KALA 0.31
- GTIM 0.12
- MACD
- KALA -0.07
- GTIM -0.02
- Stochastic Oscillator
- KALA 21.55
- GTIM 22.02
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; kids; breakfast; frozen custard; slides and drinks.